A network medicine approach to investigating ME/CFS pathogenesis in severely ill patients: a pilot study.
Hung, Li-Yuan, Wu, Chan-Shuo, Chang, Chia-Jung et al. · Frontiers in human neuroscience · 2025 · DOI
Quick Summary
Researchers used advanced computer analysis to examine genetic information from people with severe ME/CFS, looking for patterns in how genes work together. They found that ME/CFS involves multiple body systems working incorrectly, particularly the immune and nervous systems, and discovered connections to viral infections like EBV and COVID-19. The study also found clues about why more women than men develop ME/CFS, relating to how estrogen affects the body.
Why It Matters
This study provides a systems-level perspective on ME/CFS biology, moving beyond single-gene approaches to understand how multiple biological networks interact in severe disease. The identification of specific pathways—particularly viral triggers, immune dysfunction, and hormonal factors—could guide development of new diagnostic markers and targeted treatments. Understanding why women are disproportionately affected also has important implications for both research equity and clinical care.
Observed Findings
Network analysis identified a disease-associated protein module (SIPS module) enriched in genes related to fatigue, cognitive disorders, and neurodegeneration
Pathway analysis revealed significant associations between ME/CFS genes and those implicated in EBV and COVID-19 infection responses
Evidence of dysregulation in cortisol synthesis and secretion pathways
Overlap between ME/CFS-associated genes and neurodegenerative disease genes
Inferred Conclusions
ME/CFS demonstrates characteristics of a neuroimmune disorder with involvement of multiple interacting biological systems rather than single-pathway dysfunction
Viral infections, particularly EBV and COVID-19, may trigger or perpetuate ME/CFS through shared genetic vulnerability pathways
Hormonal factors, specifically estrogen signaling, may contribute to sex differences in ME/CFS prevalence and disease presentation
Specific molecular pathways identified represent potential therapeutic targets warranting further investigation
Remaining Questions
Do the identified genetic associations represent primary causes of ME/CFS or secondary consequences of the disease process?
What This Study Does Not Prove
This pilot study does not prove that any identified genes or pathways cause ME/CFS, only that they are statistically associated with the disease in this particular cohort. The findings are computational predictions based on genetic data and require experimental validation to confirm biological relevance. This study also cannot establish whether identified associations are primary causes, secondary effects, or compensatory responses to the underlying disease process.